 YAVNE, Israel, Jan. 05, 2021 GLOBE NEWSWIRE -- MediWound Ltd. Nasdaq: MDWD, a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that it will participate in the forthcoming LifeSci Partners 10th Annual Corporate Access Event and the H.C. Wainwright BioConnect 2021 Conference. Both conferences will take place virtually. 